The 2023 Australian Cell Cycle, DNA Repair and Telomere Meeting has now ended.

Melbourne Museum, Australia

October 23-25, 2023

Note that this page refers to the 2023 meeting. For the 2025 meeting go straight to http://www.australiancellcycle.org

The cell cycle, DNA damage, and telomeres are crucial factors in the development and progression of cancer and other human disease. Targeting these processes holds great potential for the development of new therapies. Therapies like CDK4/6 inhibitors, PARP inhibitors and ATR inhibitors are at the cutting edge of clinical trials.

To advance research in this field, we held the 18th Australian Cell Cycle, DNA Damage, and Telomeres meeting. It was part of a pure science-focused series that started in 1998 as a small gathering of 35 researchers and has since grown into a flagship event with over 200 Australian and international researchers and clinicians.

Topics of the meeting were:

– Genome Stability in human disease
– Telomeres and DNA damage response
– Cell Cycle and Senescence
– Genomic signatures in cancer
– Recombination and Replication
– Immune response and genome stability
– Telomere and telomerase regulation
– Cell Cycle in Cancer and Therapy
– New therapeutic opportunities in cell cycle DNA repair and telomere research

Organising committee:

• Andrew Deans (St Vincent’s Institute, Meeting Chair)
• Liz Caldon, (Garvan Institute),
• Wayne Crismani (SVI),
• Shom Goel (Peter Mac)
• Mathew Jones (University of Queensland),
• Hilda Pickett (Children’s Medical Research Institute),
• Elaine Sanij (SVI),
• Clare Scott (WEHI), 
• Vi Wickramasinghe (Peter Mac),
• Lee Wong (Monash University)

Students, postdocs and trainees

We also held an education and networking event on Sunday 22 October.

–